FDA approves condoms designed especially for anal sex

Source: web capture Pinterest

For the first time, U.S. regulators have officially authorized a condom specifically to be used for anal sex, to decrease risk of STIs.


The FDA (Food and Drug Administration) in the US has finally, on Wednesday (23 February), approved a condom specifically designed for anal sex.


Although ‘regular’ condoms are and should be used to help prevent STI transmission during anal sex, they have only ever been approved to market for vaginal sex.


It is hoped that the One Male Condom, developed by Global Protection Corp (GPC), will help decrease the risk of sexually transmitted infections during anal sex, including HIV. 


The condom will be natural rubber latex and will offer three different versions: standard, thin and fitted. The fitted condoms will be available in 54 different sizes and there will be a paper template available to find the perfect fit based on your penis. 


If only Zara would offer the same service for their menswear, more on that later. 

The FDA noted that they will also “help reduce the risk of pregnancy and the transmission of STIs during vaginal intercourse.”

“Before today’s authorization, the FDA had not cleared or approved condoms specifically indicated for anal intercourse,” the agency said.

“While today’s authorization underscores the public health importance of condoms tested and labelled specifically for anal intercourse, all other FDA-cleared condoms can continue to be used for contraception and STI prevention,” the FDA added.

Founder of GPC, Davin Wedel, told the New York Times:

 “This landmark shift demonstrates that when researchers, advocates, and companies come together, we can create a lasting impact in public health efforts.

“I think most people would be surprised to know that condoms are not approved for anal sex.”

“With this new designation from the FDA, people will have more confidence using condoms for anal sex.”

The company held a clinical trial to test the ability of the condoms in preventing transfer of bodily fluids. The study included 252 straight men between ages 18 and 54.

The FDA had said it would accept a five percent failure rate, which previous trials had failed to accomplish, however the limit was easily surpassed in the new study, with the failure rate 0.68 percent for anal intercourse and 1.89 percent for vaginal intercourse. 

The researchers suggested that one of the reasons the trial succeeded was likely because the study encouraged the use of lubricant and they introduced instructions on how to use the product.